SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Art of Investing -- Ignore unavailable to you. Want to Upgrade?

To: Sun Tzu who wrote (3472)1/29/2022 9:35:11 AM
From: Lou Weed  Respond to of 10711
 
I got in and out of LABU today for a quick profit. That thing is a real rollercoaster. I noticed that it seems to ebb and flow with the NAS



To: Sun Tzu who wrote (3472)1/29/2022 10:55:51 AM
From: stuffbug1 Recommendation

Recommended By
Sun Tzu

  Read Replies (3) | Respond to of 10711
 
Someone brought BIB to my attention. It is a double levered ETF that tracks the Nasdaq Biotech Index (IBB). The IBB is not as volatile as the XBI. From its peak last July, the IBB has declined by 31%. Over the same time frame, XBI is off 40%.

Looking to use a leveraged ETF for an intermediate term position. Since the double levered ETfs are far more forgiving on non-optimal entries, I may go with BIB.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News